Virological response and resistance profile in virologically suppressed HIV-1 infected individuals switching to a bictegravir based treatment in clinical practice

被引：0
|
作者：
Armenia, D. [1 ]
Forbici, F. [2 ]
Bertoli, A. [3 ]
Berno, G. [2 ]
Malagnino, V. [4 ]
Gagliardini, R. [2 ]
Borghi, V. [5 ]
Gennari, W. [5 ]
Cicalini, S. [2 ]
Buonomini, A. [6 ]
Teti, E. [4 ]
Latini, A. [6 ]
Sarmati, L. [4 ]
Mussini, C. [5 ]
Andreoni, M. [4 ]
Antinori, A. [2 ]
Perno, C. F. [7 ]
Ceccherini-Silberstein, F. [3 ]
Santoro, M. M. [3 ]
机构：
[1] St Camillus Int Univ Hlth Sci, Rome, Italy
[2] IRCCS, Natl Inst Infect Dis L Spallanzani, Rome, Italy
[3] Univ Roma Tor Vergata, Rome, Italy
[4] Polyclin Rome Tor Vergata, Rome, Italy
[5] Polyclin Modena, Modena, Italy
[6] IRCCS, San Gallicano Dermatol Inst, Rome, Italy
[7] Bambino Gesu Pediat Hosp, Rome, Italy
来源：
HIV MEDICINE | 2021年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
BPD1/2
引用
收藏
页码：26 / 28
页数：3
相关论文
共 50 条
  • [31] Dynamics of Total and Intact HIV-1 DNA in Virologically Suppressed Patients Switching to DTG-Based or ATV-Based Dual Therapy
    Dragoni, Filippo
    Rossetti, Barbara
    Lombardi, Francesca
    Raffaelli, Chiara Spertilli
    Bartolini, Niccolo
    Giammarino, Federica
    Moschese, Davide
    Di Giambenedetto, Simona
    Fabbiani, Massimiliano
    De Luca, Andrea
    Vicenti, Ilaria
    Zazzi, Maurizio
    Saladini, Francesco
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2022, 91 (04) : 381 - 389
  • [32] Efficacy and safety of bictegravir plus lenacapavir: 48-week outcomes in virologically suppressed people with HIV-1 on complex antiretroviral regimens at baseline
    Mounzer, K.
    Slim, J.
    Ramgopal, M.
    Hedgcock, M.
    Bloch, M.
    Santana, J.
    Mendes, I.
    Zhang, X.
    Sklar, P.
    Montezuma-Rusca, J. M.
    Segal-Maurer, S.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2024, 27 : 16 - 16
  • [33] Virological response and resistance profile in HIV-1-infected patients starting darunavir-containing regimens
    Armenia, D.
    Di Carlo, D.
    Maffongelli, G.
    Borghi, V.
    Alteri, C.
    Forbici, F.
    Bertoli, A.
    Gori, C.
    Giuliani, M.
    Nicastri, E.
    Zaccarelli, M.
    Pinnetti, C.
    Cicalini, S.
    D'Offizi, G.
    Ceccherini-Silberstein, F.
    Mussini, C.
    Antinori, A.
    Andreoni, M.
    Perno, C. F.
    Santoro, M. M.
    HIV MEDICINE, 2017, 18 (01) : 21 - 32
  • [34] Bikswitch study: Effectiveness and safety of switching to a bictegravir-based antiretroviral therapy regimen from non-integrase inhibitor-based therapies in virologically suppressed HIV-infected patients
    Perez, F.
    Jover, F.
    Delgado, E.
    Peris, J.
    Bernabeu, M. A.
    HIV MEDICINE, 2023, 24 : 72 - 73
  • [35] Virological and immunological effects of treatment interruptions in HIV-1 infected patients with treatment failure
    Miller, V
    Sabin, C
    Hertogs, K
    Bloor, S
    Martinez-Picado, J
    D'Aquila, R
    Larder, B
    Lutz, T
    Gute, P
    Weidmann, E
    Rabenau, H
    Phillips, A
    Staszewski, S
    AIDS, 2000, 14 (18) : 2857 - 2867
  • [36] Clinical Outcomes of Virologically-Suppressed Patients with Pre-existing HIV-1 Drug Resistance Mutations Switching to Rilpivirine/Emtricitabine/Tenofovir Disoproxil Fumarate in the SPIRIT Study
    Porter, Danielle P.
    Toma, Jonathan
    Tan, Yuping
    Solberg, Owen
    Cai, Suqin
    Kulkarni, Rima
    Andreatta, Kristen
    Lie, Yolanda
    Chuck, Susan K.
    Palella, Frank
    Miller, Michael D.
    White, Kirsten L.
    HIV CLINICAL TRIALS, 2016, 17 (01): : 29 - 37
  • [37] Efficacy and Safety of Switching to Dolutegravir/Lamivudine in Virologically Suppressed People Living with HIV-1 Aged Over 65 Years
    Calza, Leonardo
    Colangeli, Vincenzo
    Legnani, Giorgio
    Cretella, Silvia
    Bon, Isabella
    Viale, Pierluigi
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2024, 40 (02) : 73 - 79
  • [38] Interest of proviral HIV-1 DNA genotypic resistance testing in virologically suppressed patients candidate for maintenance therapy
    Allavena, C.
    Rodallec, A.
    Leplat, A.
    Hall, N.
    Luco, C.
    Le Guen, L.
    Bernaud, C.
    Bouchez, S.
    Andre-Garnier, E.
    Boutoille, D.
    Ferre, V.
    Raffi, F.
    JOURNAL OF VIROLOGICAL METHODS, 2018, 251 : 106 - 110
  • [39] Analysis of virological response to therapy and resistance profile in treatment-experienced and naive HIV-1 infected Romanian patients receiving regimens containing darunavir boosted with ritonavir or cobicistat
    Marin, Ruxandra-Cristina
    Streinu-Cercel, Adrian
    Moleriu, Lavinia Cristina
    Bungau, Simona Gabriela
    BIOMEDICINE & PHARMACOTHERAPY, 2022, 150
  • [40] Drug resistance mutations among virological failure HIV-1 infected patients in Malaysia
    Zain, Mohd R.
    Ibrahim, N.
    Ismail, S.
    Mat-Rahim, N. A.
    Suppiah, J.
    Thayan, R.
    Rashid, Zainol Z.
    Saat, Z.
    TROPICAL BIOMEDICINE, 2016, 33 (03) : 486 - 493
12345